What your Bard PowerPort claim could be worth

At this point in the litigation, it is speculative to attempt to assign a value to Bard PowerPort cases due to the number of variables that have yet to be resolved.

But if reasonable assumptions can be made about the validity of claims and evidence of causation, then realistic estimates can be made using similar mass tort settlements. These figures offer a working reference for what compensation might look like, though individual outcomes will always vary.

How device occurrence affects settlement value

Settlement value begins with the type of device failure or occurrence that happened with the PowerPort. The two primary occurrences are fracture and migration, with the strongest cases involving both fracture and migration occurring together. Beyond the occurrence type, individual case value depends primarily on the specific injuries resulting from the device failure.

PowerPort complications primarily produce vascular damage, embolism or stroke, thrombosis or blood clots, and infection. Cases involving vascular damage from fracture or migration carry the clearest causation and the most objective evidence of injury. Thrombosis and pulmonary embolism cases may be more medically serious, but face harder causation questions since clots can form for many reasons. Infections are low on the settlement scale because the injuries are generally less severe, can often be treated with antibiotics, and are hard to directly attribute to the device.

Settlement compensation ranges by injury classification

Settlement compensation varies considerably based on injury type and severity. The estimates below come from comparable product defect and mass tort settlements and give a sense of where different case types tend to land:

• Vascular damage cases: $175,000 to $350,000 when fracture or migration directly causes blood vessel injury with documented imaging or surgical evidence showing device-caused damage
• Thrombosis and blood clot cases: $100,000 to $250,000 depending on clot location, stroke risk, post-thrombotic syndrome complications, and difficulty establishing causation
• Infection cases: $30,000 to $100,000 for port site or bloodstream infections because infection is treatable and causation is difficult to prove
• Fractured catheters with complications: $250,000 to $1,000,000 or more when imaging or device removal provides proof of fracture with embolism risk or vascular injury
• Serious infections requiring hospitalization: $150,000 to $400,000 involving hospital admission, IV antibiotic therapy, port explant surgery, and treatment interruption
• Pulmonary embolism cases: $125,000 to $300,000, depending on clot severity, hospitalization duration, stroke risk, and ongoing anticoagulation therapy requirements

Trial verdicts produce significantly higher compensation

Settlement compensation in mass tort cases reflects negotiated outcomes, but trial verdicts tend to be significantly higher because juries can impose punitive damages and hold manufacturers liable for gross negligence. Cases that go to trial could see awards of $2,000,000 to $10,000,000 or more. The first bellwether trial resulted in a hung jury on design defect, which means that the liability theory is still very much alive heading into future trials.

Factors influencing settlement amounts within ranges

Actual settlements within these ranges depend on multiple specific factors affecting overall case strength and value. Cases with the strongest footing include imaging evidence of fracture or migration, surgical records documenting device or fragment removal, hospital records showing infection with culture results confirming port contamination, anticoagulation documentation of thrombosis treatment, and records showing cancer treatment was delayed because of port failure.

A weak case usually comes down to missing objective evidence of failure, injuries minor enough not to need surgery, difficulty tying the harm to the device rather than another cause, or patients whose other medical conditions could explain the injury on their own. Settlement value is notably higher when cancer treatment was interrupted by device failure than when the problem was caught and fixed without disrupting ongoing therapy.

Using these estimates for claim evaluation

These settlement value ranges are intended to give a realistic baseline for what different PowerPort injuries might be worth in compensation. They are working estimates reflecting actual injury patterns in the litigation and how similar product defect cases have settled in the past. They are working estimates and reasonable projections, not guarantees, based on available evidence and mass tort history.

How much your case is worth depends on your injury type, the strength of your medical records, your ability to connect the device to your harm, and where your claim stands relative to others in the MDL inventory.

Atraxia Law can evaluate your Bard PowerPort settlement potential

If you received a Bard PowerPort and experienced complications from fracture, migration, infection, thrombosis, or other device failures, your case falls within one of these settlement value categories. Knowing where your claim falls helps you make informed decisions about settlement offers and litigation strategy.

Atraxia Law can look at your Bard PowerPort case, determine your injury classification, identify where it falls in settlement ranges, and assess what compensation your situation could support. Reach out today for a free, confidential case evaluation.